<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药融圈 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-21T11:20:23+08:00</updated>
  <subtitle>药融圈PHARNEX汇聚数万医药大咖，得到数千家医药创业者鼎力支持，开展日常专题讲座。致力于成为“专业、前沿、权威、严谨”的医药行业资讯平台，以及项目、技术、工厂、融资、股权投资等资源整合平台。欢迎您关注药融圈，共同碰撞“药”的火花!</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>13年新药艰难路-首个国产ALK恩沙替尼终上市；价格曝光</title>
    <updated>2020-12-20T23:13:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/0fbAAVbzyeXIeeCkRtWfiA</id>
    <link href="https://mp.weixin.qq.com/s/0fbAAVbzyeXIeeCkRtWfiA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>上海光于科技-自动化溶出方案和服务供应商</title>
    <updated>2020-12-20T23:13:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/rvlA9aVIOp7ihcM6GKTUdg</id>
    <link href="https://mp.weixin.qq.com/s/rvlA9aVIOp7ihcM6GKTUdg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BD交易|赛生药业1.2亿美元引进Y-mAbs两款药物大中华区权益</title>
    <updated>2020-12-20T23:13:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/Pm7MD84s-LMWnBDvJ8fG4A</id>
    <link href="https://mp.weixin.qq.com/s/Pm7MD84s-LMWnBDvJ8fG4A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【免费参会】首届“中国制药MAH创新大会” 暨“MAH制度下的发展与创新”主题峰会即将开幕！</title>
    <updated>2020-12-20T23:13:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/l5t1Fw9HYVKjfIQvo942_A</id>
    <link href="https://mp.weixin.qq.com/s/l5t1Fw9HYVKjfIQvo942_A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>用心做药的亚宝药业</title>
    <updated>2020-12-20T23:13:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/TrKR6BxfHLH-gpdoXCY3Zg</id>
    <link href="https://mp.weixin.qq.com/s/TrKR6BxfHLH-gpdoXCY3Zg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>鲜明比对：安进KRAS美国提交上市申请，中国卡在遗传办</title>
    <updated>2020-12-20T23:13:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/SwFCniiXgPuF8kXj3BcsGw</id>
    <link href="https://mp.weixin.qq.com/s/SwFCniiXgPuF8kXj3BcsGw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【议程发布】“华北地区”药物技术峰会暨仿制药一致性评价大会</title>
    <updated>2020-12-20T23:13:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/KbiATPvZ4JhIcdZJCKKlYw</id>
    <link href="https://mp.weixin.qq.com/s/KbiATPvZ4JhIcdZJCKKlYw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国化学会开启会士制度，117位创始会士，43位首届会士名单！一批医药科学家当选！</title>
    <updated>2020-12-20T23:13:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/V7NhI2cirqergGNgu7lNSg</id>
    <link href="https://mp.weixin.qq.com/s/V7NhI2cirqergGNgu7lNSg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>低调CDMO | 六合宁远走出隐匿模式，冲击创业板</title>
    <updated>2020-12-20T00:11:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/l-3H2PuGyLOds5dm_ga6TA</id>
    <link href="https://mp.weixin.qq.com/s/l-3H2PuGyLOds5dm_ga6TA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一切为了患者 | 卡瑞利珠单抗治疗晚期肺癌患者生存期创历史最佳</title>
    <updated>2020-12-20T00:11:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/dGgn2lnzDfm4KOh-PSzrig</id>
    <link href="https://mp.weixin.qq.com/s/dGgn2lnzDfm4KOh-PSzrig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【免费参会】首届“中国制药MAH创新大会” 暨“MAH制度下的发展与创新”主题峰会即将开幕！</title>
    <updated>2020-12-20T00:11:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/IFyOe9bPDoe_4bKXkj2zGA</id>
    <link href="https://mp.weixin.qq.com/s/IFyOe9bPDoe_4bKXkj2zGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BE数据严重缺陷，官方暂停34个仿制药上市许可</title>
    <updated>2020-12-20T00:11:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/_QWGjGbOc8qanVlqt9OFZw</id>
    <link href="https://mp.weixin.qq.com/s/_QWGjGbOc8qanVlqt9OFZw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>GSK拟46亿美元收购罕见病公司Eidos Therapeutics</title>
    <updated>2020-12-20T00:11:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/B4-N_cgBFhksE69SQ4YMWg</id>
    <link href="https://mp.weixin.qq.com/s/B4-N_cgBFhksE69SQ4YMWg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>华润双鹤收购天东制药38.75%股权布局肝素抗凝领域</title>
    <updated>2020-12-20T00:11:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/ajLYXsoiy7a-WJOiMyIEcw</id>
    <link href="https://mp.weixin.qq.com/s/ajLYXsoiy7a-WJOiMyIEcw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【议程发布】“华北地区”药物技术峰会暨仿制药一致性评价大会</title>
    <updated>2020-12-20T00:11:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/cBgiP9R616t598nr4-262Q</id>
    <link href="https://mp.weixin.qq.com/s/cBgiP9R616t598nr4-262Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶向受体复合物，精准GPCRs药物开发策略</title>
    <updated>2020-12-20T00:11:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/vCXqYXkjrZ47SeSoA6DRRg</id>
    <link href="https://mp.weixin.qq.com/s/vCXqYXkjrZ47SeSoA6DRRg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>高昂“长寿药”NMN被广泛追捧，众多企业鏖战市场</title>
    <updated>2020-12-18T22:12:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/HSvKYxmhirzkPyHXII09Nw</id>
    <link href="https://mp.weixin.qq.com/s/HSvKYxmhirzkPyHXII09Nw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>山东盛之源-集新药研发、药品一致性评价、医药中间体开发、相容性研究、包装密封性研究、药品食品保健品检验检测服务为一体</title>
    <updated>2020-12-18T22:12:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/AK_63Xhl6w7kEolHhBWwjA</id>
    <link href="https://mp.weixin.qq.com/s/AK_63Xhl6w7kEolHhBWwjA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>EQT拟21亿美元收购瑞典小分子CDMO龙头Recipharm</title>
    <updated>2020-12-18T22:12:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/QgU3ZcgY4UG8xFddzRXoig</id>
    <link href="https://mp.weixin.qq.com/s/QgU3ZcgY4UG8xFddzRXoig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>非小细胞肺癌靶向新药--KRAS G12C抑制剂</title>
    <updated>2020-12-18T22:12:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/Vs43X11IPl6xegQaA2DzbQ</id>
    <link href="https://mp.weixin.qq.com/s/Vs43X11IPl6xegQaA2DzbQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>